Nuclear phospholipase C in biological control and cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Critical Reviews in Eukaryotic Gene Expression

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1615/CRITREVEUKARGENEEXPR.V21.I3.50PMID 22111715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myelodysplastic syndromes.

  2010cited by this paper
• Myelodysplastic syndromes: A practical approach to diagnosis and treatment

  2010cited by this paper
• A limited number of 5-azacitidine cycles can be effective treatment in MDS

  2009cited by this paper
• Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology.

  2009cited by this paper
• A novel gene expression pathway regulated by nuclear phosphoinositides.

  2009cited by this paper
• Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

  2009cited by this paper
• Nuclear PLCbeta1 is required for 3T3-L1 adipocyte differentiation and regulates expression of the cyclin D3-cdk4 complex.

  2009cited by this paper
• Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.

  2009cited by this paper
• Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS

  2009cited by this paper
• Involvement of nuclear PLCβl in lamin B1 phosphorylation and G2/M cell cycle progression

  2009cited by this paper
• PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes.

  2008cited by this paper
• Nuclear phospholipase C beta1 and cellular differentiation.

  2008cited by this paper
• Multiple roles of phosphoinositide-specific phospholipase C isozymes.

  2008cited by this paper
• Phospholipase C-δ1 Expression Is Linked to Proliferation, DNA Synthesis, and Cyclin E Levels*

  2008cited by this paper
• Identification of Cyclin A2 as the Downstream Effector of the Nuclear Phosphatidylinositol 4,5-Bisphosphate Signaling Network*

  2008cited by this paper
• Lipid signalling in disease

  2008cited by this paper
• Activated Nuclear Metabotropic Glutamate Receptor mGlu5 Couples to Nuclear Gq/11 Proteins to Generate Inositol 1,4,5-Trisphosphate-mediated Nuclear Ca2+ Release*

  2008cited by this paper
• Nuclear diacylglycerol kinase‐ζ is a negative regulator of cell cycle progression in C2C12 mouse myoblasts

  2007cited by this paper
• Two waves of the nuclear phospholipase C activity in serum-stimulated HL-60 cells during G(1) phase of the cell cycle.

  2007cited by this paper
• CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine

  2007cited by this paper
• Nuclear phospholipid signaling: phosphatidylinositol-specific phospholipase C and phosphoinositide 3-kinase

  2007cited by this paper
• Proteomic‐based analysis of nuclear signaling: PLCβ1 affects the expression of the splicing factor SRp20 in Friend erythroleukemia cells

  2006cited by this paper
• The Retinoblastoma Family Proteins Bind to and Activate Diacylglycerol Kinaseζ*

  2006cited by this paper
• Subnuclear localization and differentiation‐dependent increased expression of DGK‐ζ in C2C12 mouse myoblasts

  2006cited by this paper
• Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome.

  2006cited by this paper
• Structural Determinants for Phosphatidic Acid Regulation of Phospholipase C-β1*

  2006cited by this paper
• PLCzeta(zeta): a sperm protein that triggers Ca2+ oscillations and egg activation in mammals.

  2006cited by this paper
• Nuclear phospholipase C beta1 (PLCbeta1) affects CD24 expression in murine erythroleukemia cells.

  2005cited by this paper
• Nuclear phospholipase C-beta1b activation during G2/M and late G1 phase in nocodazole-synchronized HL-60 cells.

  2005cited by this paper
• Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation.

  2005cited by this paper
• Nuclear Translocation of Phospholipase C-δ1 Is Linked to the Cell Cycle and Nuclear Phosphatidylinositol 4,5-Bisphosphate*

  2005cited by this paper
• PIKE/nuclear PI 3‐kinase signaling in preventing programmed cell death

  2005cited by this paper
• Cell cycle-dependent Ca2+ oscillations in mouse embryos are regulated by nuclear targeting of PLCζ

  2004cited by this paper
• PIKE GTPase: a novel mediator of phosphoinositide signaling

  2004cited by this paper
• Ca2+ oscillation-inducing phospholipase C zeta expressed in mouse eggs is accumulated to the pronucleus during egg activation.

  2004cited by this paper
• Phospholipase C-γ1 is a guanine nucleotide exchange factor for dynamin-1 and enhances dynamin-1-dependent epidermal growth factor receptor endocytosis

  2004cited by this paper
• SHIP-2 and PTEN Are Expressed and Active in Vascular Smooth Muscle Cell Nuclei, but Only SHIP-2 Is Associated with Nuclear Speckles*

  2003cited by this paper
• Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus.

  2003cited by this paper
• Up-regulation of nuclear PLCbeta1 in myogenic differentiation.

  2003cited by this paper
• The myelodysplastic syndrome(s): a perspective and review highlighting current controversies.

  2003cited by this paper
• Molecular characterization of the human PLC beta1 gene.

  2002cited by this paper
• Phospholipase Cγ1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE

  2002cited by this paper
• Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells.

  2002cited by this paper
• PLC zeta: a sperm-specific trigger of Ca(2+) oscillations in eggs and embryo development.

  2002cited by this paper
• Type I PIPkinases interact with and are regulated by the retinoblastoma susceptibility gene product-pRB.

  2002cited by this paper
• Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.

  2002cited by this paper
• Phosphorylation of Nuclear Phospholipase C β1 by Extracellular Signal-Regulated Kinase Mediates the Mitogenic Action of Insulin-Like Growth Factor I

  2001cited by this paper
• Phosphatidylinositol 3-Kinase C2α Contains a Nuclear Localization Sequence and Associates with Nuclear Speckles*

  2001cited by this paper
• Cytoplasmic and nuclear phospholipase C-beta 1 relocation: role in resumption of meiosis in the mouse oocyte.

  2000cited by this paper
• A role for nuclear phospholipase Cbeta 1 in cell cycle control.

  2000cited by this paper
• Critical Role Played by Cyclin D3 in the MyoD-Mediated Arrest of Cell Cycle during Myoblast Differentiation

  1999cited by this paper
• Phospholipase C-δ1 Contains a Functional Nuclear Export Signal Sequence*

  1999cited by this paper
• Phosphatidylinositol 4,5-bisphosphate reverses the inhibition of RNA transcription caused by histone H1.

  1998cited by this paper
• Mapping of a Molecular Determinant for Protein Kinase C βII Isozyme Function*

  1998cited by this paper
• Localization of two forms of phospholipase C-beta1, a and b, in C6Bu-1 cells.

  1998cited by this paper
• Regulation of PtdIns4P 5-kinase C by thrombin-stimulated changes in its phosphorylation state in human platelets.

  1998cited by this paper
• Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells.

  1998cited by this paper
• Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling.

  1998cited by this paper
• A Role for Nuclear Phosphatidylinositol-specific Phospholipase C in the G2/M Phase Transition*

  1997cited by this paper
• Essential role for nuclear phospholipase C beta1 in insulin-like growth factor I-induced mitogenesis.

  1997cited by this paper
• Changes in the components of a nuclear inositide cycle during differentiation in murine erythroleukaemia cells.

  1995cited by this paper
• Protein kinase C chimeras: catalytic domains of alpha and beta II protein kinase C contain determinants for isotype-specific function.

  1995cited by this paper
• Nuclear phosphatidylinositols decrease during S-phase of the cell cycle in HeLa cells.

  1994cited by this paper
• Phosphoinositide signaling in nuclei of Friend cells: phospholipase C beta down-regulation is related to cell differentiation.

  1994cited by this paper
• Identification of nuclear beta II protein kinase C as a mitotic lamin kinase.

  1994cited by this paper
• Identification of protein kinase C (PKC) phosphorylation sites on human lamin B. Potential role of PKC in nuclear lamina structural dynamics.

  1993cited by this paper
• Phosphoinositide signalling enzymes in rat liver nuclei: phosphoinositidase C isoform beta 1 is specifically, but not predominantly, located in the nucleus.

  1993cited by this paper
• A differential location of phosphoinositide kinases, diacylglycerol kinase, and phospholipase C in the nuclear matrix.

  1992cited by this paper
• Nuclear localization and signalling activity of phosphoinositidase Cβ in Swiss 3T3 cells

  1992cited by this paper
• Selective translocation of beta II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells.

  1991cited by this paper
• Changes in nuclear inositol phospholipids induced in intact cells by insulin-like growth factor I.

  1989cited by this paper
• Synthesis of polyphosphoinositides in nuclei of Friend cells. Evidence for polyphosphoinositide metabolism inside the nucleus which changes with cell differentiation.

  1987cited by this paper

• A Causal Relationship Between the Lipidome and Central Nervous System Tumors.

  2025cites this paper
• PLCβ1 by-passes early growth response -1 to induce the differentiation of neuronal cells

  2024cites this paper
• Advances in MDS/AML and inositide signalling.

  2023cites this paper
• Multiple functions of phospholipase Cβ1 at a glance.

  2022cites this paper
• Potential therapeutic targets shared between leishmaniasis and cancer

  2021cites this paper
• Phospholipases D1 and D2 regulate cell cycling in primary prostate cancer cells and are differentially associated with the nuclear matrix

  2021cites this paper
• Phospholipase C families: Common themes and versatility in physiology and pathology.

  2020cites this paper
• Glycogen Synthase Kinase-3 and phospholipase C-beta signalling: Roles and possible interactions in myelodysplastic syndromes and acute myeloid leukemia.

  2020cites this paper
• Phosphoinositide-Dependent Signaling in Cancer: A Focus on Phospholipase C Isozymes

  2020influential citation
• Pre-proof Phospholipase C families : Common themes and versatility in physiology and pathology

  2020cites this paper
• Recent advances in MDS mutation landscape: Splicing and signalling.

  2019cites this paper
• Nuclear translocation of PKC‐ α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs)

  2017cites this paper
• Selective Activation of Nuclear PI-PLCbeta1 During Normal and Therapy-Related Differentiation.

  2016cites this paper
• Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes

  2016cites this paper
• Phosphoinositide-specific phospholipase C in health and disease

  2015cites this paper
• Phosphoinositide-specific Phospholipase C β 1b (PI-PLCβ1b) Interactome: Affinity Purification-Mass Spectrometry Analysis of PI-PLCβ1b with Nuclear Protein*

  2013cites this paper